Abstract
A method is provided for determining pulmonary embolism and/or increased risk thereof in a human being, comprising collecting a sample of exhalation air from said human being and determining the presence or absence in said exhaled air of one or more biomarkers associated with pulmonary embolism. Additionally, a kit that comprises the means for detecting at least one biomarker associated with pulmonary embolism or risk thereof is provided.
| Original language | English |
|---|---|
| IPC | G01N33/68 |
| Patent number | WO2020245200A1 |
| Filing date | 10/12/2020 |
| Country/Territory | Denmark |
| Priority date | 03/06/2019 |
| Priority number | EP20190177903 |
| Publication status | Published - 2020 |